Skip to content
zameds

Morphine (Srm Rhotard)

Morphine

Ascendis Pharma (Pty) Ltd

Registration

Applicant
Ascendis Pharma (Pty) Ltd
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Srm rhotard 10

EACH TABLET CONTAINS MORPHINE SULPHATE 10 mg

10Y0355Y/2.9/355RegisteredNot determinedNone
Srm rhotard 30

EACH TABLET CONTAINS MORPHINE SULPHATE 30 mg

30Y0356Y/2.9/356RegisteredNot determinedNone
Srm rhotard 60

EACH TABLET CONTAINS MORPHINE SULPHATE 60 mg

60Y0357Y/2.9/357RegisteredNot determinedNone
Srm rhotard 100

EACH TABLET CONTAINS MORPHINE SULPHATE 100 mg

100Y0358Y/2.9/358RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S6: Morphine

    • except preparations and mixtures of morphine containing 0,2 percent or less of morphine, calculated as anhydrous morphine. (S2)

    Consolidated Schedules 06 July 2026, lines 10318 to 10319

  • S2: Morphine

    • mixtures containing 0,2 percent or less of morphine, calculated as anhydrous morphine.

    Consolidated Schedules 06 July 2026, line 2355

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C17H19NO3285.34 g/mol

(4R,4AR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol

Drag to rotate. Structure from PubChem CID 5288826.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles